Influenza vaccine (H1N1, GlaxoSmithKline)

N/A

Report date: 2026/03/13 20:02:36

Base Information

Drug NameInfluenza vaccine (H1N1, GlaxoSmithKline)

Drug Alias NameH1N1流感裂解灭活佐剂疫苗 (GlaxoSmithKline)A/California/7/2009 （H1N1）v株Pandemrix

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusN/A

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02